Olema holds annual meeting; stockholders elect three directors, approve say-on-pay, ratify E&Y auditor

Olema Pharmaceuticals, Inc.

Sean P. Bohen, Yi Larson, and Andrew Rappaport elected as Class III directors through 2026 with votes 23.5M, 18.0M, and 23.7M for respectively.
Advisory vote on executive compensation approved: 18.7M for, 1.9M against, 5.0M abstain, 5.8M broker non-votes.
Ratification of Ernst & Young as independent auditor for FY2023 approved: 30.9M for, 10k against, 540k abstain.
Broker non-votes of 5.8M shares present on director and compensation proposals.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Olema Pharmaceuticals, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2023-06-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Proposal 3— Ratification of Selection of Independent Registered Public Accounting Firm Final Voting Results For Against Abstain 30,921,828 10,323 540,055

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Olema Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-06-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Proposal 1— Election of Directors Final Voting Results Nominees For Withheld Broker Non-Votes Sean P. Bohen, M.D., Ph.D. 23,524,203 2,123,064 5,824,939 Yi Larson 17,980,507 7,666,760 5,824,939 Andrew Rappaport 23,727,247 1,920,020 5,824,939

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Olema Pharmaceuticals, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-06-15 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-15

Exact text from the filing

Proposal 2— Advisory Vote on Executive Compensation Final Voting Results For Against Abstain Broker Non-Votes 18,713,603 1,912,571 5,021,093 5,824,939

View on SEC.gov

1181 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Olema Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-011291

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.